Scientific work

Doç. Dr. Emine Gültürk

58 publications. The source of the information is stated next to each publication.

Back to profile

  1. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03363-8 PMID 42565930 Open-access full textSource: OpenAlex

  2. Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2026

    DOI 10.55730/1300-0144.6184 PMID 42058976 Open-access full textSource: OpenAlex

  3. Evaluation of bloodstream infections in febrile neutropenic patients with hematological malignancy: a retrospective cohort study

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13465-6 PMID 42056949 2 citations (Europe PMC) Open-access full textSource: ORCID

  4. Innovative Cancer Drugs: Medicolegal Assessments on Efficacy and Necessity

    Sakarya Medical Journal, 2026

    DOI 10.31832/smj.1798059 Open-access full textSource: ORCID

  5. CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Mediterranean Journal of Hematology and Infectious Diseases, 2026

    DOI 10.4084/mjhid.2026.027 PMID 41821563 Open-access full textSource: ORCID

  6. Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study

    Nigerian Journal of Clinical Practice, 2025

    DOI 10.4103/njcp.njcp_499_24 PMID 40462333 Open-access full textSource: OpenAlex

  7. Psychiatric Manifestations in Polycythemia Vera: A Case of Refractory Delirium and Psychosis Responding to Hematological Treatment

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025

    DOI 10.4274/tjh.galenos.2025.2025.0060 PMID 40297865 Open-access full textSource: Europe PMC

  8. Atypic Primary Ovarian Lymphoma Presenting with Hypercalcemia: A Rare Case Report

    Bezmialem Science, 2025

    DOI 10.14235/bas.galenos.2025.08216 Open-access full textSource: OpenAlex

  9. The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia

    Immunologic Research, 2025

    DOI 10.1007/s12026-025-09672-z PMID 40768060 1 citation (Europe PMC) Source: ORCID

  10. Exploring the potential of blood and urine protein electrophoresis in predicting 1-year mortality in acute kidney injury

    Plos One, 2025

    DOI 10.1371/journal.pone.0327044 PMID 40561005 1 citation (Europe PMC) Open-access full textSource: ORCID

  11. Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology

    Journal of Thrombosis and Thrombolysis, 2025

    DOI 10.1007/s11239-024-03043-5 PMID 39527392 5 citations (Europe PMC) Source: ORCID

  12. Presentation of Multiple Myeloma with Extramedullary Plasmacytoma After Autologous Stem Cell Transplantation

    Turkiye Klinikleri Journal of Case Reports, 2025

    DOI 10.5336/caserep.2025-111284 Open-access full textSource: OpenAlex

  13. Brentuximab Vedotin Monotherapy in Relapsed/Refractory T Cell Lymphoma Setting-Real Life Data

    Hitit Medical Journal, 2024

    DOI 10.52827/hititmedj.1320606 Open-access full textSource: OpenAlex

  14. SECONDARY SOLID CANCER FREQUENCY AND RISK FACTORS IN PHILADELPHIA- NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.04.005 Open-access full textSource: OpenAlex

  15. Secondary Solid Cancers Among Patients with Philadelphia Chromosome- Negative Myeloproliferative Neoplasms: A Multicenter Study

    Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2024.2024.0199 PMID 39113479 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  16. MPN-176 Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)01410-1 Source: OpenAlex

  17. Clinical Significance of CALR Mutation in Patients With Essential Thrombocythemia

    Clinical Lymphoma Myeloma & Leukemia, 2024

    DOI 10.1016/s2152-2650(24)00711-0 Source: OpenAlex

  18. The Systemic Inflammation Index: A New Candidate Minor Criterion in the Diagnosis of Polycythemia Vera

    Journal of Personalized Medicine, 2024

    DOI 10.3390/jpm14050471 PMID 38793053 4 citations (Europe PMC) Open-access full textSource: ORCID

  19. Monoclonal Gammopathy of Undetermined Significance is Not Associated with Renal Cell Carcinoma

    Eurasian Journal of Medical Advances, 2024

    DOI 10.14744/ejma.2024.63644 Open-access full textSource: ORCID

  20. Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans

    Blood Coagulation & Fibrinolysis, 2024

    DOI 10.1097/mbc.0000000000001307 PMID 38973518 1 citation (Europe PMC) Source: ORCID

  21. Systemic Inflammation Index: A New Candidate Minor Criterion in the Diagnosis of Polycythemia vera

    Preprints.org, 2024

    DOI 10.20944/preprints202403.0449.v1 Open-access full textSource: ORCID

  22. Alectinib-induced Non-immune Hemolytic Anemia due to Erythrocyte Membrane Alterations: A Retrospective Evaluation

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2024

    DOI 10.4274/bmj.galenos.2024.2024.3-9 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  23. Relationship between Immune Thrombocytopenic Purpura and Thyroid Diseases

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2024

    DOI 10.4274/bmj.galenos.2024.2024.7-2 Open-access full textSource: OpenAlex

  24. RETROSPECTIVE EVALUATION OF BONE MARROW FINDINGS IN AUTOIMMUNE HEMOLYTIC ANEMIAS

    Hematology Transfusion and Cell Therapy, 2023

    DOI 10.1016/j.htct.2023.09.068 Open-access full textSource: OpenAlex

  25. Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey

    Journal of Chemotherapy, 2023

    DOI 10.1080/1120009x.2023.2208439 PMID 37211906 3 citations (Europe PMC) Source: ORCID

  26. Temporal relationship between thromboembolic events and myeloproliferative neoplasm diagnosis: is it associated with mortality risk?

    European review for medical and pharmacological sciences, 2023

    DOI 10.26355/eurrev_202306_32611 PMID 37318468 Source: ORCID

  27. Contribution of lowered hemoglobin threshold value in the diagnosis of polycythemia vera: Comparison of 2016 and 2008 WHO criteria

    Medicine, 2023

    DOI 10.1097/md.0000000000034462 PMID 37543796 2 citations (Europe PMC) Open-access full textSource: ORCID

  28. Systemic Immune-Inflammation Index and Hodgkin Lymphoma: an Underexplored Relationship

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.62582 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  29. Risk Factors Associated with Progression of Myelodysplastic Syndrome: 13 Years of Experience from a Single Center

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.36693 Open-access full textSource: OpenAlex

  30. Geriatrik Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2208 Open-access full textSource: OpenAlex

  31. PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA

    HemaSphere, 2022

    DOI 10.1097/01.hs9.0000851128.52895.ec 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  32. IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY

    Mediterranean Journal of Hematology and Infectious Diseases, 2022

    DOI 10.4084/mjhid.2022.074 PMID 36425152 6 citations (Europe PMC) Open-access full textSource: ORCID

  33. Increased Perforin- and IL-21-Expressing NK Cells in Patients with Early-Stage Chronic Lymphocytic Leukemia

    Experimed, 2022

    DOI 10.26650/experimed.1191622 2 citations (OpenAlex) Open-access full textSource: ORCID

  34. ALECTINIB-RELATED ERYTHROCYTE MEMBRANE CHANGES, NON-IMMUNE HEMOLYSIS AND ERYPTOSIS

    Hematology, Transfusion and Cell Therapy, 2022

    DOI 10.1016/j.htct.2022.09.1259 Open-access full textSource: ORCID

  35. RITUXIMAB INDUCED LUNG DISEASE IN A MANTLE CELL LYMPHOMA PATIENT RECEIVING MAINTENANCE: CASE PRESENTATION

    Hematology, Transfusion and Cell Therapy, 2022

    DOI 10.1016/j.htct.2022.09.1245 Open-access full textSource: ORCID

  36. IgG4 producing POEMS syndrome: A rarely recognized subtype.

    Indian journal of pathology & microbiology, 2021

    DOI 10.4103/ijpm.ijpm_995_20 PMID 34341279 1 citation (Europe PMC) Open-access full textSource: ORCID

  37. An Experience on Pomalidomide in Patients within Relapsed/Refractory Multiple Myeloma - A Multicenter Study in Turkey

    Journal of Pharmaceutical Research International, 2021

    DOI 10.9734/jpri/2020/v32i4131047 Open-access full textSource: ORCID

  38. Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data

    Blood, 2020

    DOI 10.1182/blood-2020-138899 Source: OpenAlex

  39. The Turkish experience with therapeutic plasma exchange: A national survey

    Transfusion and Apheresis Science, 2019

    DOI 10.1016/j.transci.2019.04.015 PMID 31036516 6 citations (Europe PMC) Open-access full textSource: ORCID

  40. Bleomycin-Induced Flagellate Dermatitis

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2019

    DOI 10.4274/tjh.galenos.2019.2018.0317 PMID 30600679 6 citations (Europe PMC) Open-access full textSource: ORCID

  41. Hematolojik malignitelerde trombosit süspansiyonu replasman deneyimimiz

    2018

    Source: OpenAlex

  42. Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.

    Journal of clinical pathology, 2016

    DOI 10.1136/jclinpath-2015-203320 PMID 26811428 5 citations (Europe PMC) Open-access full textSource: ORCID

  43. Siklosporin İle İlişkili Allogeneik Hematopoetik Kök Hücre Nakli Sonrası Gelişen Posterior Reversibl Ensefalopati Sendromu Pres Olgu Sunumu

    AYBU AVESIS, 2016

    Source: OpenAlex

  44. Hodgkin's Disease Presenting with Chronic Pruritis and Cutaneous Involvement.

    Journal of clinical and diagnostic research : JCDR, 2015

    DOI 10.7860/jcdr/2015/11075.5382 PMID 25738023 Open-access full textSource: ORCID

  45. Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

    Blood, 2015

    DOI 10.1182/blood.v126.23.2783.2783 2 citations (OpenAlex) Source: ORCID

  46. Bone marrow transplantation for Behcet's disease: a case report and systematic review of the literature

    Rheumatology, 2014

    DOI 10.1093/rheumatology/ket479 PMID 24505123 29 citations (Europe PMC) Source: ORCID

  47. Successful management of chronic refractory immune thrombocytopenia with laparoscopic splenectomy in a patient with acute promyelocytic leukemia.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2012

    DOI 10.1007/s12288-012-0173-8 PMID 24426368 2 citations (Europe PMC) Open-access full textSource: ORCID

  48. Eosinophilic Gastroenteritis Associated with Rheumatoid Arthritis

    Turkish Journal of Rheumatology, 2011

    DOI 10.5606/tjr.2011.051 3 citations (OpenAlex) Open-access full textSource: ORCID

  49. CLLU1 Gene Expression Level As a Prognostic Parameter in Patients with Chronic Lymphocytic Leukemia

    Blood, 2011

    DOI 10.1182/blood.v118.21.4603.4603 Source: ORCID

  50. Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

    Blood, 2011

    DOI 10.1182/blood.v118.21.4429.4429 1 citation (OpenAlex) Source: ORCID